Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-03

Clinical Trial Update: Nitrous Oxide for PTSD [Phase 2]

View source ↗

Summary

Phase 2 trial of nitrous oxide for PTSD was terminated with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrous oxide (nitrous oxide)

Snippet

Sponsor: VA Office of Research and Development | Conditions: PTSD | Phase 2 | Status: TERMINATED | Results posted: 2023-03-03